Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Joerg Putzke"'
Publikováno v:
Biodrugs
Since the approval and availability of the first biosimilar in 2015 in the United States (US), evidence regarding the post-marketing safety of cancer supportive care biosimilars remains limited.The aim was to explore the adverse event (AE) reporting